Home › Funds › SRH U.S. Quality GARP ETF
Fund family: Elevation Series Trust · Filed by Elevation Series Trust (CIK 1936157) · SEC series S000077516
Ticker: SRHQ (C000237993)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 631 with, 26 against, 0 abstentions (not counted as with management). Shareholder proposals: 12 FOR, 14 AGAINST, 0 abstained, by the filing’s own vote-source field.
No item-level comparison with other Elevation Series Trust funds is possible: no ballot item of this fund was voted by at least three other funds of the family with a clear majority.
The same votes as “with management” above, by the sector of the company voted on. 99.2% of this fund’s 657 such votes could be given a sector; the other 5 (0.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 214 | 15 | 7.0% |
| Technology | 127 | 1 | 0.8% |
| Industrials | 102 | 4 | 3.9% |
| Health Care | 88 | 4 | 4.5% |
| Finance | 56 | 1 | 1.8% |
| Consumer Staples | 42 | 1 | 2.4% |
| Utilities | 18 | 0 | 0.0% |
| Miscellaneous | 5 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 479 | 0 |
| Say-on-Pay | 61 | 0 |
| Audit-related | 60 | 0 |
| Compensation | 24 | 1 |
| Corporate Governance | 18 | 11 |
| Environment or Climate | 6 | 6 |
| Other Social Issues | 6 | 6 |
| Shareholder Rights and Defenses | 2 | 1 |
| Capital Structure | 1 | 0 |
| Extraordinary Transactions | 1 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Ciena Corporation | March 26, 2026 | $23M | 5 | 0 |
| Frontdoor, Inc. | May 13, 2026 | $13M | 10 | 0 |
| Cardinal Health, Inc. | November 5, 2025 | $11M | 14 | 0 |
| Keysight Technologies, Inc. | March 19, 2026 | $10M | 7 | 1 |
| Jabil Inc. | January 22, 2026 | $10M | 10 | 1 |
| Watts Water Technologies, Inc. | May 19, 2026 | $9M | 11 | 0 |
| Humana Inc. | April 16, 2026 | $9M | 14 | 1 |
| EMCOR Group, Inc. | June 4, 2026 | $9M | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 19, 2026 | Keysight Technologies, Inc. | Consider, on a non-binding advisory basis, a Stockholder Proposal: Shareholder Ability to Call for a Special Shareholder Meeting Shareholder proposal | For | Against |
| January 22, 2026 | Jabil Inc. | Vote on a stockholder proposal requesting stockholder right to act by written consent. Shareholder proposal | For | Against |
| April 16, 2026 | Humana Inc. | The stockholder proposal requesting shareholder approval requirement for excessive golden parachutes, if properly presented at the meeting. Shareholder proposal | For | Against |
| May 14, 2026 | Cboe Global Markets, Inc. | Stockholder proposal regarding shareholder right to act by written consent. Shareholder proposal | For | Against |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposal | For | Against |
| June 10, 2026 | Target Corporation | Shareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposal | Against | For |
| May 19, 2026 | Amgen Inc. | Stockholder proposal to require an independent board chairman. Shareholder proposal | Against | For |
| May 7, 2026 | Corpay, Inc. | Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. Shareholder proposal | For | Against |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | For | Against |
| May 13, 2026 | Akamai Technologies, Inc. | To vote upon a shareholder proposal requiring the Company to provide a report on political spending. Shareholder proposal | For | Against |
| May 13, 2026 | Elevance Health, Inc. | Shareholder Proposal Requesting an Independent Study on the Impact of Prohibiting Corporate Contributions to Partisan 527 Tax-Exempt Political Groups. Shareholder proposal | Against | For |
| May 21, 2026 | The Home Depot, Inc. | Shareholder Proposal Regarding Evaluation of Recycling-Related Plastics Targets Shareholder proposal | Against | For |
659 ballot items at 61 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, SRH U.S. Quality GARP ETF (SRHQ) voted at 61 shareholder meetings of 61 companies, on 659 ballot items in all. Where management made a recommendation, the fund followed it on 96.0% of the items and voted against it 26 times. Its most frequent area of disagreement was corporate governance (11 of its votes against management). It voted on 26 shareholder proposals.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.